Previous Article | Next Article ![]()
J. Virol., Aug 1997, 6061-6067, Vol 71, No. 8
JJ Meulenberg, AP van Nieuwstadt, A van Essen-Zandbergen and JP Langeveld
GP4 is a minor structural glycoprotein encoded by ORF4 of Lelystad virus
(LV). When it was immunoprecipitated from cell lysates and extracellular
virus of CL2621 cells infected with LV, it was shown to have an apparent
molecular mass of approximately 28 and 31 kDa, respectively. This
difference in size occurred because its core N- glycans were modified to
complex type N-glycans during the transport of the protein through the
endoplasmic reticulum and Golgi compartment. A panel of 15 neutralizing
monoclonal antibodies (MAbs) reacted with the native GP4 protein expressed
by LV and the recombinant GP4 protein expressed in a Semliki Forest virus
expression system. However, these MAbs did not react with the GP4 protein
of U.S. isolate VR2332. To map the binding site of the MAbs, chimeric
constructs composed of ORF4 of LV and VR2332 were generated. The reactivity
of these constructs indicated that all the MAbs were directed against a
region spanning amino acids 40 to 79 of the GP4 protein of LV. Six MAbs
reacted with solid-phase synthetic dodecapeptides. The core of this site
consists of amino acids 59 to 67 (SAAQEKISF). Comparison of the amino acid
sequences of GP4 proteins from various European and North American isolates
indicated that the neutralization domain spanning amino acids 40 to 79 is
the most variable region of GP4. The neutralization domain of GP4,
described here, is the first identified for LV.
Copyright © 1997, American Society for Microbiology
Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus
Institute for Animal Science and Health, Lelystad, The Netherlands. J.J.Meulenberg@id.dlo.nl
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|